Increased Survival of Patients Treated With a Vaccinia Melanoma Oncolysate Vaccine

Abstract

Although VMO vaccine therapy in surgical adjuvant setting did not produce a significant survival benefit to all patients with melanoma, patients from the above two subsets had significant survival benefit.